Home › Funds › Summit Street Capital Management, LLC › ELV

Summit Street Capital Management, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Summit Street Capital Management, LLC reported holding 72,040 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$27.9M, representing 3.91% of its reported portfolio and ranking #6 among its reported holdings. Summit Street Capital Management, LLC has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)72.04K sh
Reported value held$27.86M
Portfolio Weight3.91%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Summit Street Capital Management, LLC's ELV position evolved

Summit Street Capital Management, LLC first disclosed a stake in ELV in Q3 2023 at 13,465 shares (US$5.9M). The position peaked in Q2 2026 at 72,040 shares, worth US$27.9M. Across 12 filings, Summit Street Capital Management, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 72,040 shares valued at US$27.9M — a reduction of -1,943 shares quarter over quarter.. Notable position changes include a 133% increase in Q4 2024 (shares rose 18% over the following quarter), a 57% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.46K $5.86M New
Q4 2023 13.46K $6.35M Hold
Q1 2024 15.89K $8.24M Add
Q2 2024 16.94K $9.18M Add
Q3 2024 16.94K $8.81M Hold
Q4 2024 39.42K $14.54M Add
Q1 2025 40.57K $17.65M Add
Q2 2025 33.91K $13.22M Reduce
Q3 2025 53.19K $17.19M Add
Q4 2025 62.90K $22.05M Add
Q1 2026 73.98K $21.66M Add
Q2 2026 72.04K $27.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Summit Street Capital Management, LLC held ELV?

Summit Street Capital Management, LLC has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Summit Street Capital Management, LLC's current position in ELV?

As of Q2 2026, Summit Street Capital Management, LLC holds 72.04K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $27.86M, representing 3.91% of its reported portfolio and ranking #6.

Has Summit Street Capital Management, LLC been buying or selling ELV?

In the latest 13F filing (Q2 2026), Summit Street Capital Management, LLC reduced its position in ELV. The position peaked in Q2 2026 at 72.04K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.